Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
International Journal of Antimicrobial Agents|May 4, 2020
Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatmentSandra P Smieszek, Bart P Przychodzen, Mihael H PolymeropoulosJournal of the Royal Society, Interface|August 22, 2014
Progressive promoter element combinations classify conserved orthogonal plant circadian gene expression modulesSandra P Smieszek, Haixuan Yang, Alberto Paccanaro, et al.Frontiers in Genetics|October 17, 2022
Case report: A novel missense variant in melanopsin associates with delayed sleep phenotype: Whole genome sequencing studySandra P Smieszek, Christos M Polymeropoulos, Gunther Birznieks, et al.Journal of Global Antimicrobial Resistance|July 17, 2021
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibilitySandra P Smieszek, Vasilios M Polymeropoulos, Changfu Xiao, et al.Cytokine|August 6, 2021
Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'Sandra P Smieszek, Bartlomiej P Przychodzen, Vasilios M Polymeropoulos, et al.Frontiers in Plant Science|September 4, 2023
Improved chilling tolerance in glasshouse-grown potted sweet basil by end-of-production, short-duration supplementary far red lightFirdous U Begum, George Skinner, Sandra P Smieszek, et al.Clinical and Translational Gastroenterology|March 17, 2022
Enrichment of Motilin Receptor Loss-of-Function Variants in GastroparesisSandra P Smieszek, Jesse L Carlin, Changfu Xiao, et al.Cytokine|February 5, 2022
Elevated plasma levels of CXCL16 in severe COVID-19 patientsSandra P Smieszek, Vasilios M Polymeropoulos, Christos M Polymeropoulos, et al.Virology|May 22, 2022
Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infectionPrabhakaran Kumar, Manikannan Mathayan, Sandra P Smieszek, et al.Frontiers in Neurology|October 3, 2022
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trialChristos M Polymeropoulos, Vasilios M Polymeropoulos, Emily L Czeisler, et al.Pageof 2